Drivers and barriers influencing healthcare provider antiviral prescribing decisions for patients with mild-to-moderate COVID-19: a discrete choice experiment

This publication has 33 references indexed in Scilit:

• Prediction accuracy of discrete choice experiments in health-related research: a systematic review and meta-analysis
  eClinicalMedicine, 2024
• Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID‐19: An Analysis of the National COVID Cohort Collaborative (N3C)
  Pharmacoepidemiology and Drug Safety, 2024
• Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults
  Infectious Diseases and Therapy, 2024
• Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis
  Journal of Medical Virology, 2024
• Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
  The Lancet Regional Health - Americas, 2024
• Clinical Risk and Outpatient Therapy Utilization for COVID-19 in the Medicare Population
  JAMA Health Forum, 2024
• Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
  The Lancet Infectious Diseases, 2023
• COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
  Nature Reviews Nephrology, 2022
• Discrete Choice Experiments in Health Economics: Past, Present and Future
  PharmacoEconomics, 2018
• Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
  Value in Health, 2013